Clinical Trials Browser

Active not recruiting × Interventional × tebentafusp × Clear all

NCT04262466 2026-03-06

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Phase 1/2 Active not recruiting

Other solid neoplasm

Select Advanced Solid Tumors

NCT05315258 2025-07-17

TebeMRD

Phase 2 Active not recruiting

Uveal Melanoma, Melanoma